BlueScope spurns $10.7 billion offer, but leaves door open to talks
BlueScope spurns $10.7 billion offer, but leaves door open to talks
Source link
Similar Posts
Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress – Bio Tech Winners
June 13, 2024 by Leave a Comment Last Updated on June 13, 2024 by [#item_full_content] Like this: Like Loading… Related Filed Under: biotech news, News Reader Interactions This site uses Akismet to reduce spam. Learn how your comment data is processed. Source link
Boost Your CPP Payouts by $3,800 Annually: Here’s How
The Canada Pension Plan (CPP) payment is for life, but more is needed to live on or support financial needs in retirement. CPP users should heed the advice of the Canada Pension Plan Investment Board (CPPIB). The CPP fund manager says the pension is a foundation for Canadians to build their financial security in retirement….
The rise of SME IPOs
Source: Mint Source link
Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
SAVA Cassava Sciences $21.85 -4.17 (-16.03%) (As of 08/9/2024 ET) 52-Week Range $8.79 ▼ $42.20 Price Target $119.00 Cassava Sciences NASDAQ: SAVA has become a hot topic among traders and active market participants thanks to its recent surge in volatility, liquidity, and overall market performance. Over the past month, shares have climbed 133% and are now…
